Abiogen Pharma’s marketing activity aims at maximizing the results of its drugs and affirming its licensed products. It is the leading company on the market for bone metabolism thanks to the marketing of the four Bisphosphonates (Etidron, Clasteon Alendros and Nerixia) fruit of its Research Centre.

Gladio (Aceclophenac) also lies in this field, a new anti-inflammatory evolved from the traditional FANS for the treatment of osteoarticular pathologies.

The company is strongly involved in the respiratory therapeutic area, with Broncho-Munal, a highly specialized bioengineered product obtained from bacterial lisates with low molecular weight, important in the prevention of pathologies of the higher and lower respiratory system, and Bornilene, a spray effective in diseases of the oral cave. These products have consented Abiogen Pharma to develop a tight collaboration with Paediatricians and Pneumatologists.